“Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture”, Tikrit J. Pharm. Sci., vol. 20, no. 1, pp. 20–32, Jun. 2026, doi: 10.25130/tjphs.2026.20.1.3.20.32.